Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2014
Crenolanib is a selective type I pan-FLT3 inhibitorCatherine Choy Smith, Elisabeth A Lasater, Kimberly C Lin, et al.
Cancer Cell|March 31, 2004
BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpointJamil Dierov, Raia Dierova, Martin Carroll
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 12, 2013
The oncogene eIF4E: using biochemical insights to target cancerMartin Carroll, Katherine L B Borden
Blood Advances|February 7, 2022
Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinibCatherine C Smith, Mark J Levis, Alexander E Perl, et al.
Frontiers in Oncology|May 28, 2021
Radiation Therapy for Chemotherapy Refractory Gingival Myeloid SarcomaDaniel Y Lee, Jonathan Baron, Christopher M Wright, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-Tikhonenko
Blood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin Carroll
Pageof 19